Search For "biocon biologics"
EMA approves Biocon Biologics' new monoclonal antibodies facility, renews
Updated : 1 year, 9 months ago IST
According to a press release, this facility, designed to produce multiple drug substances, will now commence the production of biosimilar Bevacizumab, enhancing the company's capacity to meet the growing demand for biologics across European markets.
Read More
Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafil
Updated : 1 year, 10 months ago IST
Biocon Biologics announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the company informed the exchange in a filing.
Read More
No impact on industry of move to withdraw Rs 2000 notes from circulation:
Updated : 2 years, 10 months ago IST
Mittal told ANI in an interview that a large portion of retail sales in pharmacies happen through digital modes
Read More
Dr Devi Shetty and Kiran Mazumdar Shaw Inaugurated 10-Bedded BMT Unit at M
Updated : 3 years, 1 month ago IST
Bengaluru (Karnataka) [India], February 3 (ANI/NewsVoir): With a vision to strengthen its presence in cancer care solutions in Karnataka region, Dr Devi Shetty, Chairman & Executive Director, Narayana Health and Kiran Mazumdar Shaw, Executive Chairperson - Biocon Limited and Biocon Biolo
Read More
Biocon Biologics appoints Shreehas Tambe as MD, CEO
Updated : 3 years, 3 months ago IST
Tambe takes over from Arun Chandavarkar, who will continue to serve as a non-executive, non-independent director on the board of Biocon Biologics.
Read More
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Busi
Updated : 3 years, 3 months ago IST
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi
Read More
Biocon subsidiary completes acquisition of Viatris for USD 3 billion
Updated : 3 years, 3 months ago IST
According to a statement by the pharma company, Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the US Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors, respectively.
Read More
Delhi HC grants bail to joint drug controller of CDSCO
Updated : 3 years, 6 months ago IST
Delhi [India], September 6 (ANI): The Delhi High Court on Tuesday granted bail to the Joint Drug Controller of the Central Drugs Standard Control Organisation (CDSCO) and a Biocon Biologics executive in a Rs 9 lakh bribery case.
Read More
CBI arrests Biocon Biologics official in bribery case; company denies alle
Updated : 3 years, 9 months ago IST
New Delhi [India], June 21 (ANI): The Central Bureau of Investigation (CBI) on Tuesday arrested Biocon Biologics Associate Vice President L Praveen Kumar in a bribery case involving Joint Drugs Controller S Eswara Reddy.
Read More
Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.33
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd (BBL) will acquire Viatris'
Read More
SII announces strategic partnership with Biocon Biologics
Updated : 4 years, 6 months ago IST
New Delhi [India], September 17 (ANI): Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited (BB
Read More
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Updated : 4 years, 6 months ago IST
Bengaluru (Karnataka) [India], Sep 17 (ANI): Biocon Biologics Ltd (BBL) and Serum Institute Life Sciences (SILS) have announced a strategic alliance in a bid to make a significant impact on global healthcare through vaccines and biologics.
Read More